Skip to content

Chronic Kidney Disease in Pakistani Population

Chronic Kidney Disease in the Pakistani Population

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00800878
Acronym
CKD
Enrollment
650
Registered
2008-12-02
Start date
2008-02-29
Completion date
2010-04-30
Last updated
2008-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Keywords

Chronic Kidney Disease, Renal insufficiency

Brief summary

The Indo-Asian developing countries are facing an epidemic of chronic diseases including hypertension, diabetes and chronic kidney disease (CKD). Diagnosis of early CKD is essential for institution of effective and timely prevention of its complications; costly late stage treatment for end stage renal disease is currently an unfeasible option in these populations. GFR estimates of kidney function provide a common reference standard for all people and are therefore readily applicable by physicians and understood by patients. However, the existing GFR equations yield widely discrepant results in the Indo Asian population, and none of the currently available estimating equations have been validated in this population. The main objective is to develop a tool which can be used for screening subjects at high risk for developing CKD (with hypertension and diabetes) as well as the general population.

Detailed description

The proposed study is being conducted at the Aga Khan University in collaboration with Tufts-New England Medical Center and Imperial College, UK. It is a population based cross-sectional study using a 2-stage cluster design. The study would be performed on 650 adult subjects from the general population in Karachi. A new GFR equation specific to a Pakistani population would be developed and validated using the gold standard of measured Insulin GFR. The performance of the new equation will be compared to the existing ones developed in other populations with respect to bias, precision, and accuracy. The project is likely to contribute significantly to moving the field to kidney disease forward, and its results are likely to have far reaching implications for understanding of CKD and, ultimately, its prevention in Indo-Pakistani populations worldwide.

Interventions

None listed

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
Aga Khan University
Lead SponsorOTHER

Study design

Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All individuals aged 40 years and above

Exclusion criteria

* Shortness of breath on minimal to moderate exertion * Acute fibril illness * Doctor diagnosed liver disease * Doctor diagnosed rheumatological disease * Heart attack within past three months * Pregnancy * Mentally incompetent to give informed consent * Too frail to travel to clinic * Bed ridden subjects

Design outcomes

Primary

MeasureTime frame
GFR will be measured as the mean of at least two urinary clearance periods of Inulin

Countries

Pakistan

Contacts

Primary ContactTazeen H Jafar, MD, MPH
tazeen.jafar@aku.edu92 21 4930051

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026